Zoom Video Communications Inc (NASDAQ:ZM) stock gained after the video conferencing platform’s second quarter earnings impressed and it raised its full-year outlook.
Revenue grew 4.7% from the year-ago quarter to $1.22 billion, ahead of Wall Street estimates of $1.2 billion.
Instacart (NASDAQ:CART) shares moved lower after Wedbush downgraded the company to ‘Underperform’ from ‘Neutral’ and lowered its price target to $42 from $55, with analysts citing intensifying competition in the grocery delivery space.
“Instacart has demonstrated healthy gross transaction volume (GTV) growth and an improving margin trajectory over the last few quarters, tempering some investor concern,” the analysts wrote.
Nvidia Corp (NASDAQ:NVDA, ETR:NVD) shares dipped, Palantir Technologies Inc (NYSE:PLTR) wobbled, and the familiar cries of “tech bubble” rang out again.
Wedbush’s Dan Ives, though, thinks the bears have it wrong: just as they did in 2023, 2024, and every pullback since.
Microsoft Corp's (NASDAQ:MSFT) newly announced enterprise pricing overhaul is “significant” and potentially supports stronger revenue growth in the cloud, according to UBS.
Analyst Karl Keirstead reiterated a 'Buy' rating and $650 price target, implying more than 27% upside from current levels.
Federal Reserve Chair Jerome Powell will deliver his highly anticipated Jackson Hole speech on Friday at 10 am Eastern Time, with markets focused on the outlook for interest rates amid mixed signals from the labor market and inflation.
Deutsche Bank analysts expect Powell to strike a more balanced tone than at July’s FOMC meeting, when he called the labor market “solid” and inflation still too high.
Artificial intelligence stocks, including Palantir Technologies Inc (NYSE:PLTR), Nvidia Corp (NASDAQ:NVDA, ETR:NVD) and Advanced Micro Devices Inc (NASDAQ:AMD, ETR:AMD), traded lower on Wednesday amid a broader tech-sector selloff, highlighting growing investor caution after an extended run-up in valuations.
Palantir led the declines, tumbling 7.5% in early trading after a 9% drop on Tuesday, to trade hands at about $145.
General Motors Company (NYSE:GM) had its price target raised by Wedbush to $65 from $55, with analysts pointing to the automaker’s handling of tariffs and product pipeline as drivers of growth through 2026.
The firm maintained its ‘Outperform’ rating on the automaker, which traded hands at $57 on Tuesday afternoon.
Palo Alto Networks Inc (NYSE:PANW, ETR:5AP)’s recent earnings report was “impressive on all fronts,” analysts at Bank of America said Tuesday, pointing to strong fundamentals and better-than-expected fiscal 2026 guidance.
“At a high level, the company’s strategy appears to be working well, with 1,400 platform deals, and software is driving up growth, accounting now for 56% of product revenues vs. 44% last year,” Bank of America analysts wrote in a note.
Walmart Inc (NYSE:WMT, ETR:WMT) is set to report its second quarter earnings this week, with Bank of America analysts expecting the discussion to center less on headline numbers and more on the forces shaping the retailer’s longer-term trajectory.
For Q2, the analysts project adjusted EPS of $0.70 and US comparable sales growth of 3.5% for the quarter, in line with the Wall Street consensus.
Meta Platforms Inc (NASDAQ:META, ETR:FB2A, SWX:FB) is undergoing another overhaul of its artificial intelligence operations, a move that highlights both the strategic importance and challenges of the company’s AI ambitions, according to Bank of America analysts.
According to a report from The Information, the company intends to divide its Superintelligence Labs unit into four groups: a “TBD Lab,” a products team that includes the Meta AI assistant, an infrastructure team, and the Fundamental AI Research lab.
Stifel has reiterated its 'buy' rating on Hikma Pharmaceuticals PLC (LSE:HIK, OTC:HKMPF), arguing that the shares look compellingly cheap even as debate intensifies over margins in the key Injectables division.
First-half results were broadly in line at group level, but Injectables profitability slipped.
CVS Health Corp (NYSE:CVS) has been upgraded by UBS analysts who cited greater confidence in the company’s recovery trajectory and multiple levers for earnings growth.
The analysts upped their rating to ‘Buy’ from ‘Neutral’ and raised their price objective to $79 from $67, implying upside from its share price on Monday afternoon of about $70.
Bank of America Corp (NYSE:BAC) analysts have repeated their ‘Neutral’ rating on UnitedHealth Group Inc (NYSE:UNH, ETR:UNH) after Berkshire Hathaway disclosed a new investment in the health insurer, calling the move a positive signal but not enough to resolve key uncertainties in the near term.
“The question is less 'Is there upside?', and more 'When will it be realized?'" the analysts wrote. “We generally are favorable on UnitedHealth and see the potential for upside in 2027, which would likely lead to upside in the multiple as well.”